Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials - Tran, S; Retnakaran, R; Zinman, B (Diabetes Obes Metab, 2018)